World Cancer Day: UNSW experts available for interview

This World Cancer Day, a range of UNSW Medicine & Health cancer researchers, clinicians and scientists are available for media interviews across all aspects of cancer, from prevention and detection to treatment and survivorship.
UNSW Media | UNSW Newsroom

Associate Professor Caroline Ford is an ovarian cancer researcher. She can talk about the importance of shining a light on underfunded and under-researched cancers, including gynaecological cancers – and the need to increase awareness, reduce stigma and invest in research.

Scientia Professor Michael Barton, OAM, is the Principal of cancer research for UNSW Medicine. He can talk about the wide range of cancer research at UNSW, the global demand for cancer services, and how the MRI linac will revolutionise cancer treatment.

Associate Professor Phoebe Phillips is a pancreatic cancer researcher. She can talk about why pancreatic cancer is so devastating and its outcomes so poor, and discuss the opportunities created by UNSW’s collaborative effort with the Sydney Partnership for Health, Education, Research and Enterprise (SPHERE).

Professor Afaf Girgis, AM, is a behavioural scientist. She can talk about how cancer affects everyone, not just patients – for example, how partners and carers experience high levels of distress as well and therefore need support. She can also speak about the importance of asking patients directly about their experience, and how we need more accessible psychosocial care for all patients.

Dr Orazio Vittorio is a UNSW Scientia Fellow and researcher at the Children’s Cancer Institute. He can talk broadly about childhood cancer – brain cancer in particular. He can also speak about PET imaging and how it’s revolutionised the imaging of oncology patients, and opportunities to evaluate the potential beneficial effects of repurposing drugs to treat aggressive childhood cancers.

Conjoint Professor Michelle Haber, AM, is a leading childhood cancer researcher. She can talk about how childhood cancer is different from adult cancer, and why this matters. She can also explain how her research aims to discover new treatments and how childhood cancer has led the way for adult cancer treatment. Finally, she can talk about the importance of leveraging new genetic technologies to identify individual personalised treatments, and her future vision for childhood cancer research at the Children’s Cancer Institute.

Professor John Pimanda is a blood cancer specialist. He can talk about acute leukaemia, a poor-survival cancer that affects young and old people. He can also speak about The Lowy Cancer Research Centre – a major hub for blood cancer research – and how blood cancer research needs funding to uncover new targets and to develop new drugs.